A novel HLA-B*51 allele (B*5116) identified by nucleotide sequencing

Tissue Antigens

Volumn 55, Issue 2, 2000, Pages 182-184

  Tamouza, R ^a   Carbonnelle, E ^a   Schaeffer, V ^a   Sadki, K ^a,b   Abed, Y ^a   Marzais, F ^a   Poirier, J C ^a   Fortier, C ^a   Toubert, A ^a   Raffoux, C ^a   Charron, D ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSTITUT NATIONAL D HYGIÈNE   (Morocco)

Author keywords

Gene conversion; HLA B*5116; Serological typing

Indexed keywords

GLUTAMIC ACID; HLA B ANTIGEN; LEUCINE; PRIMER DNA;

ALGERIA; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CODON; ETHNIC GROUP; EXON; FRANCE; HUMAN; HUMAN CELL; LEBANON; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN;

ALLELES; AMINO ACID SEQUENCE; BASE SEQUENCE; DNA, COMPLEMENTARY; HLA-B ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 0033950859     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2000.550214.x     Document Type: Article

References (11)

1. 1. Ohno S, Ohguchi M, Hirose S, Matsuda H, Wakisaka A, Aizawa M. Close association of HLA-Bw51 with Behçet's disease. Arch Opthtalmol 1982: 100: 1455-8.
2. 2. Mizuki N, Ohno S, Tanaka K et al. Association of HLA-B51 and lack of association of class II alleles with Behçet's disease. Tissue Antigens 1992: 40: 22-30.
3. 3. Tait BD, Hammond M, Stavropoulos-Giokas C et al. AHS#4: B5, B35, B53, B18, B5102, B5103, B78. In: Charron D, ed. Genetic diversity of HLA. Functional and medical implication. Vol. I. Paris: EDK, 1996: 47-55.
4. 4. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1996. Tissue Antigens 1997: 49: 297-321.
5. 5. Marsh SGE. Nomenclature for factors of the HLA system, update March 1998. Tissue Antigens 1998: 52: 592-3.
6. 6. Tamouza R, Visser CJ, El Kassar N et al. Identification of a novel HLA-B*51 variant: HLA-B*5112. Tissue Antigens 1998: 52: 489-91.
7. 7. Iwanaga KK, Eberle M, Kolman CJ, Bermingham E, Watkins DI. Further diversification of the HLA-B locus in Central American Amerindians: B*39 and B*51 alleles in the Kuna of Panama. Tissue Antigens 1997: 50: 251-7.
8. 8. Cereb N. Kong Y, Lee S, Maye P, Yang SY. Nucleotide sequences of MHC class 1 introns 1, 2, and 3 in humans and intron 2 in nonhuman primates. Tissue Antigens 1996: 47: 498-511.
9. 9. Catipovic B, Dal Porto J, Mage M, Johansen TE, Schneck JP. Major histocompatibility complex conformational epitopes are peptide specific, J Exp Med 1992: 176: 1611-8.
10. 10. Bluestone JA, Jameson S, Miller S, Dick R II. Peptide-induced conformational changes in class 1 heavy chains alter major histocompatibility complex recognition. J Exp Med 1992: 176: 1757-61.
11. 11. Curran MD, Williams F, Earle JA et al. Long-range PCR amplification as an alternative strategy for characterizing novel HLA-B alleles. Eur J Immunogenet 1996: 23: 297-309.